NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

CANC

Tema Oncology ETF

Jul 10 • 10:21AM ET

25.85

Dollar change +0.07
Percentage change 0.29	%

Financial • Exchange Traded Fund • USA • NASD

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-4.55%	Total Holdings	50	Perf Week	2.47%
Sponsor	Tema	ETF Type		Tags	equity	Return% 3Y	-	AUM	72.15M	Perf Month	1.91%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-	NAV/sh		Perf Quarter	23.23%
Index	-	Average Maturity		Tags	-	Return% 10Y		52W High	29.85 -13.40%	Perf Half Y	4.17%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	20.10 28.66%	Perf YTD	6.36%
Active/Passive		Quant Type		Tags	-	Flows% 1M	-2.06%	Volatility	3.55% 2.31%	Perf Year	-4.39%
Dividend TTM	0.50 (1.93%)	ESG Type		Tags	-	Flows% 3M	3.36%	ATR (14)	0.65	Perf 3Y	-
Dividend Ex-Date	Dec 11, 2024	Dividend Type		Sector/Theme		Flows% YTD	41.29%	RSI (14)	59.80	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	0.97	Perf 10Y	-
Expense	0.75%	Growth/Value		SMA20	2.63%	Flows% 3Y		Rel Volume	0.79	Prev Close	25.78
Inverse/Leveraged		Market Cap		SMA50	5.13%	Flows% 5Y		Avg Volume	17.96K	Price	25.85
IPO	Aug 16, 2023	Option/Short	No / Yes	SMA200	1.42%	Trades		Volume	3,663	Change	0.29%

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your FINVIZ experience